Vinicius Ernani

1.3k total citations
50 papers, 858 citations indexed

About

Vinicius Ernani is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Vinicius Ernani has authored 50 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 15 papers in Epidemiology. Recurrent topics in Vinicius Ernani's work include Lung Cancer Research Studies (23 papers), Neuroendocrine Tumor Research Advances (15 papers) and Lung Cancer Treatments and Mutations (14 papers). Vinicius Ernani is often cited by papers focused on Lung Cancer Research Studies (23 papers), Neuroendocrine Tumor Research Advances (15 papers) and Lung Cancer Treatments and Mutations (14 papers). Vinicius Ernani collaborates with scholars based in United States, China and Brazil. Vinicius Ernani's co-authors include Thomas E. Stinchcombe, Nabil F. Saba, Taofeek K. Owonikoko, Peter J. Hosein, Apar Kishor Ganti, Jessica MacIntyre, Jaime R. Merchan, Joé U. Levi, Govindarajan Narayanan and Caio Rocha‐Lima and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Vinicius Ernani

44 papers receiving 845 citations

Peers

Countries citing papers authored by Vinicius Ernani

Since Specialization

Citations

This map shows the geographic impact of Vinicius Ernani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinicius Ernani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinicius Ernani more than expected).

Fields of papers citing papers by Vinicius Ernani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinicius Ernani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinicius Ernani. The network helps show where Vinicius Ernani may publish in the future.

Co-authorship network of co-authors of Vinicius Ernani

This figure shows the co-authorship network connecting the top 25 collaborators of Vinicius Ernani. A scholar is included among the top collaborators of Vinicius Ernani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinicius Ernani. Vinicius Ernani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	US expert Delphi consensus on the prevention and management of stomatitis in patients treated with datopotamab deruxtecan 2025 ·Supportive Care in Cancer ·Hope S. Rugo, Aditya Bardia, Débora S. Bruno, Vinicius Ernani, Erika Hamilton, Rebecca S. Heist, Komal Jhaveri, Benjamin Levy, Aaron Lisberg, Joyce O’Shaughnessy, Jacob Sands, Alexander I. Spira, Sara M. Tolaney, Nathaniel S. Treister, (unknown), Melissa M. Johnson	1
2	Targeted therapy‑associated cardiotoxicity in patients with stage‑IV lung cancer with or without cardiac comorbidities 2024 ·Oncology Reports ·Yanmei Peng, Dong Li, Jason A. Wampfler, Yung‐Hung Luo, Ashok Kumar, (unknown), (unknown), Nathan Y. Yu, Zhichao Wang, Konstantinos Leventakos, Vinicius Ernani, Ping Yang	3
3	Chemoimmunotherapy in patients with extensive‐stage small cell lung cancer and a poor performance status 2023 ·Cancer ·(unknown), (unknown), Daniel Almquist, Blake Langlais, Konstantinos Leventakos, Nathan Y. Yu, Rami Manochakian, Vinicius Ernani	7
4	Clinical outcomes of stage-IV non–small-cell lung cancer in young patients and the impact of tumor markers 2023 ·Cancer Treatment and Research Communications ·Pedro Reck dos Santos, Yalun Li, Vinicius Ernani, Jonathan D’Cunha, Marie‐Christine Aubry, Ping Yang	2
5	Chemoimmunotherapy as the First-Line Treatment for Patients With Extensive-Stage Small-Cell Lung Cancer and an ECOG Performance Status 2 or 3 2023 ·Clinical Lung Cancer ·(unknown), (unknown), Blake Langlais, Konstantinos Leventakos, Nathan Y. Yu, Daniel Almquist, Rami Manochakian, Vinicius Ernani	7
6	Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report 2023 ·Cancer Treatment and Research Communications ·Aakash Desai, Sagar Rakshit, Radhika Bansal, (unknown), (unknown), Rami Manochakian, Yanyan Lou, Yujie Zhao, Vinicius Ernani, P. Savvides, (unknown), (unknown), (unknown), Konstantinos Leventakos, Alex A. Adjei, Randolph S. Marks, Julian R. Molina, Aaron S. Mansfield, Zongming Chen, Anastasios Dimou	15
7	Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer 2023 ·Clinical Lung Cancer ·Aakash Desai, (unknown), (unknown), Jacob J. Orme, Saurabh Zanwar, (unknown), (unknown), (unknown), (unknown), Rami Manochakian, Yanyan Lou, Yujie Zhao, Vinicius Ernani, P. Savvides, Julian R. Molina, Anastasios Dimou, Aaron S. Mansfield, Kaushal Parikh, Konstantinos Leventakos	15
8	Lobar versus sublobar resection for atypical lung carcinoid: An analysis from the National Cancer Database 2022 ·Cancer ·Vinicius Ernani, Adams K. Appiah, Daniel Rodríguez Rius, Yael Kusne, (unknown), (unknown), Dawn E. Jaroszewski, Pedro Reck dos Santos, Terence T. Sio, Nathan Y. Yu, Ping Yang, Steven E. Schild, Jonathan D’Cunha	5
9	Adjuvant chemotherapy following SBRT for early stage non-small cell lung cancer (NSCLC) in older patients 2020 ·Journal of Geriatric Oncology ·Madison Grinnell, Adams K. Appiah, Michael J. Baine, Vinicius Ernani, Alissa Marr, (unknown), Weining Zhen, Laxmi Narayana Buddharaju, Lynette M. Smith, Apar Kishor Ganti	3
10	The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) and adjuvant chemotherapy 2020 ·Cancer Treatment and Research Communications ·Vinicius Ernani, Adams K. Appiah, Michael J. Baine, Lynette M. Smith, Apar Kishor Ganti	2
11	HPV Status and Survival in Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck 2019 ·Anticancer Research ·(unknown), Adams K. Appiah, Avyakta Kallam, Vinicius Ernani, Lynette M. Smith, Apar Kishor Ganti	34
12	A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): A Fred and Pamela Buffet Cancer Center Clinical Trials Network study 2019 ·Cancer Treatment and Research Communications ·Vinicius Ernani, Rahat Jahan, Lynette M. Smith, Alissa Marr, (unknown), (unknown), (unknown), (unknown), Imayavaramban Lakshmanan, (unknown), Sanchita Rauth, Kavita Mallya, Mohd W. Nasser, Maneesh Jain, Anne Kessinger, Surinder K. Batra, Apar Kishor Ganti	4
13	Management of Brain Metastases in Non–Small-Cell Lung Cancer 2019 ·Journal of Oncology Practice ·Vinicius Ernani, Thomas E. Stinchcombe	110
14	Adjuvant Systemic Therapy in Patients With Early-Stage NSCLC Treated With Stereotactic Body Radiation Therapy 2018 ·Journal of Thoracic Oncology ·Vinicius Ernani, Adams K. Appiah, Alissa Marr, (unknown), Weining Zhen, Lynette M. Smith, Apar Kishor Ganti	21
15	The nab-paclitaxel/gemcitabine regimen for patients with refractory advanced pancreatic adenocarcinoma 2018 ·Journal of Gastrointestinal Oncology ·(unknown), Peter J. Hosein, Isildinha M. Reis, (unknown), Vinicius Ernani, (unknown), Jessica MacIntyre, (unknown), Jaime R. Merchan, Caio M. Rocha Lima	10
16	Systemic treatment and management approaches for medullary thyroid cancer 2016 ·Cancer Treatment Reviews ·Vinicius Ernani, (unknown), Amy Y. Chen, Taofeek K. Owonikoko	31
17	Biomarkers and targeted systemic therapies in advanced non-small cell lung cancer 2015 ·Molecular Aspects of Medicine ·(unknown), Vinicius Ernani, Taofeek K. Owonikoko	25
18	Oral Cavity Cancer: Risk Factors, Pathology, and Management 2015 ·Oncology ·Vinicius Ernani, Nabil F. Saba	47
19	A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma 2012 ·BMC Cancer ·Peter J. Hosein, Jessica MacIntyre, (unknown), (unknown), Vinicius Ernani, Arturo Loaiza‐Bonilla, Govindarajan Narayanan, Afonso Ribeiro, Lorraine Portelance, Jaime R. Merchan, Joé U. Levi, Caio Rocha‐Lima	176
20	Acute Spontaneous Tumor Lysis Syndrome as the Initial Presentation of ALK-Positive Diffuse Large B-Cell Lymphoma 2012 ·Applied immunohistochemistry & molecular morphology ·Jennifer R. Chapman‐Fredricks, (unknown), (unknown), Vinicius Ernani, Offiong F. Ikpatt	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact